Reduced prevalence of serum antibodies against adeno-associated virus type 2 in patients with adult T-cell leukaemia lymphoma

Seroepidemiological studies have shown previously that cancer patients are less likely to have antibodies against the tumour suppressive adeno‐associated virus (AAV) than control groups. To examine the influence of AAV infection on the development of adult T‐cell leukaemia lymphoma (ATLL), an endemi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of medical virology 2001-09, Vol.65 (1), p.185-189
Hauptverfasser:	Walz, Christian M., Nakamura, Minoru, Fukunaga, Toshihiko, Jasiewicz, Yvonne, Edler, Lutz, Schlehofer, Jörg R., Tanaka, Yuetsu
Format:	Artikel
Sprache:	eng
Schlagworte:	AAV Adeno-associated virus 2 Adeno-associated virus type 2 Antibodies, Viral - blood ATLL Biological and medical sciences Carrier State Dependovirus - immunology EBNA1 antigen ELISA Epstein-Barr virus Female Fundamental and applied biological sciences. Psychology HTLV-I HTLV‐I, ELISA Human T-lymphotropic virus 1 Human T-lymphotropic virus 1 - immunology Humans Immunoglobulin G - blood Leukemia-Lymphoma, Adult T-Cell - immunology Leukemia-Lymphoma, Adult T-Cell - virology Male Microbiology Parvoviridae Infections - epidemiology Parvoviridae Infections - immunology Parvoviridae Infections - virology Prevalence Seroepidemiologic Studies seroepidemiology tumour suppression
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!